Skip to main content

Table 4 Allele frequency for case and control OR ODDS RATIO The increased A allele frequencies was non significantly associated with increased risk HT (OR = 0.57 (0.3–1.06)

From: Receptor of advanced glycation end product (RAGE) polymorphism and oxidative status in Hashimoto’s thyroiditis in Egyptian female patients: case control study

Allele RAGE -429 T > C

Cases group N = 80

Control group N = 80

OR (95% CI)

T

71(88%)

77(96%)

1

C

9(12%)

3(4%)

3.25(0.84–12.94)

RAGE -374 T > A

Cases group N = 80

Control group N = 80

OR (95% CI)

T

52(65%)

41(51%)

1

A

28(35%)

39(49%)

0.57 (0.3–1.06)

Gly82/ Ser82

Cases group N = 80

Control group N = 80

OR (95% CI)

Gly82 allele

74/80(92.5%)

78/80(97.5%)

1

Ser82 allele

6/80(7.5%)

2/80(2.5)

0.31(0.06–1.6)